Business in the Burbs

Regeneron reports another Q1 loss

April

Regeneron Pharmaceuticals Inc., a drug development company in Eastview, said this morning it lost $17.5 million, or 22 cents a share, in the first quarter, compared with a loss of $11.6 million, or 15 cents a share, in the first quarter of 2008.

Total revenues increased to $75 million from $56.4 million in the same period of 2008. The company said the revenue came from contract research and development, technology licensing and net product sales.

Regeneron is working on new drugs with French drugmaker Sanofi-Aventis and Bayer HealthCare.

This entry was posted on Thursday, April 30th, 2009 at 1:56 pm by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.